skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women

Journal Article · · AIP Advances
DOI:https://doi.org/10.1063/1.3699052· OSTI ID:1198166
 [1];  [2]
  1. Wiley Systems, Santa Fe, New Mexico 87505, USA
  2. Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA, Center for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
+ Show Author Affiliations

Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1198166
Journal Information:
AIP Advances, Journal Name: AIP Advances Vol. 2 Journal Issue: 1; ISSN 2158-3226
Publisher:
American Institute of PhysicsCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 1 work
Citation information provided by
Web of Science

References (32)

Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk journal January 2000
Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy journal June 1999
Age at Onset as an Indicator of Familial risk of Breast Cancer journal June 1990
The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines journal December 2003
Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay journal November 1996
Possible relationship between menopause and age at onset of breast cancer journal January 1950
A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer journal February 1992
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology journal November 2000
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment journal November 2009
Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? journal January 2003
Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study journal March 1993
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women journal February 2009
Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice journal June 2001
A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. journal May 1992
Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis journal January 1999
Morphological Changes in Breast Tissue with Menstrual Cycle journal December 2002
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy journal May 2008
Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells journal August 2003
Misrepresentations about palliative options and prognosis in motor neurone disease: some legal considerations journal February 2005
Physiological Action of Progesterone in Target Tissues journal August 1997
Benign Breast Diseases: Classification, Diagnosis, and Management journal May 2006
The roles of sex steroid receptor coregulators in cancer journal January 2002
The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG) journal February 2001
Differential SERM Effects on Corepressor Binding Dictate ERα Activity in Vivo journal December 2002
Estrogen Receptor ( ESR1 ) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer journal November 2011
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer journal November 1998
Estrogen as therapy for breast cancer journal August 2002
The significance of glucocorticoid pulsatility journal April 2008
Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. journal May 1990
The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. journal December 1994
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 journal September 2005
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial journal December 2010

Similar Records

Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor–Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative
Journal Article · Sat Jul 15 00:00:00 EDT 2017 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:1198166
+3 more
Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model
Journal Article · Sat Jun 01 00:00:00 EDT 2013 · Toxicology and Applied Pharmacology · OSTI ID:1198166
RESULTS OF HORMONE TREATMENT OF BREAST CANCER, WITH SPECIAL ATTENTION TO PROPHYLACTIC THERAPY.
Journal Article · Mon Jan 01 00:00:00 EST 1968 · Strahlentherapie, 136: 259-62(Sept. 1968). · OSTI ID:1198166

Related Subjects